These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 33302967)

  • 1. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
    Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
    J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.
    Olivieri LJ; Kellman P; McCarter RJ; Cross RR; Hansen MS; Spurney CF
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):72. PubMed ID: 27788681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
    Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.
    Starc JJ; Moore RA; Rattan MS; Villa CR; Gao Z; Mazur W; Jefferies JL; Taylor MD
    Pediatr Cardiol; 2017 Oct; 38(7):1485-1492. PubMed ID: 28762167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right Ventricular Function and T1-Mapping in Boys With Duchenne Muscular Dystrophy.
    Dual SA; Maforo NG; McElhinney DB; Prosper A; Wu HH; Maskatia S; Renella P; Halnon N; Ennis DB
    J Magn Reson Imaging; 2021 Nov; 54(5):1503-1513. PubMed ID: 34037289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping.
    Xu K; Xu HY; Xu R; Xie LJ; Yang ZG; Yu L; Zhou B; Fu H; Liu H; Cai XT; Guo YK
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):110. PubMed ID: 34645467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
    Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance.
    Earl CC; Pyle VI; Clark SQ; Annamalai K; Torres PA; Quintero A; Damen FW; Hor KN; Markham LW; Soslow JH; Goergen CJ
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):14. PubMed ID: 36793101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
    Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
    Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
    J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
    Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
    Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.
    Becker S; Florian A; Patrascu A; Rösch S; Waltenberger J; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
    J Cardiovasc Magn Reson; 2016 May; 18(1):25. PubMed ID: 27150296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
    Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.